Life Science Big News Roundup: Lexaria Receives Cannabis R&D License; Harvest One Phase II Clinical Trials on Satipharm CBD GelPell® Published in Peer-Reviewed Medical Journal Life Science Investing
T2 Biosystems Expands Rapid Diagnostic Technologies to Australia, Fiji and New Zealand Medical Device Investing